Skip to content
跳至主要內容
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
SPY
···
QQQ
···
IWM
···
DIA
···
AAPL
···
MSFT
···
NVDA
···
GOOGL
···
AMZN
···
META
···
TSLA
···
BRK.B
···
JPM
···
GLD
···
TLT
···
BTC
···
ETH
···
VIXY
···
UUP
···
USO
···
個股明細
Loading institutional stock data...
← BACK TO COCKPIT
ALL TICKERS →
OPTIONS CHAIN →
OCS
Oculis Holding AG
NASDAQGM
Biotechnology
Switzerland
$12.17
—
+0.00 (+0.00%)
CLOSED
—
OPEN
$12.07
HIGH
$12.66
LOW
$11.93
PREV CLOSE
$12.17
VOLUME
124.1K
0.32x avg
BID / ASK
8.80 / 15.29
spr 6.490
MARKET CAP
$675.8M
DAY RANGE
$11.93
$12.66
P/E (TTM)
—
Fwd -6.0
EPS (TTM)
-1.70
DIV YIELD
—
52W HIGH
$34.48
-64.7%
52W LOW
$10.52
+15.7%
BETA
0.23
vs S&P 500
DES
FA
GP
OPT
HLDR
EARN
CMP
COMPARE
ASK DESK
AFTER-HOURS
$12.12
-0.05
(-0.44%)
LAST SURPRISE
—
—
NEXT EARNINGS
—
—
CATALYST
No fresh catalyst
—
ANALYST
—
—
SHORT INT
—
—
OPTIONS IV
—
—
OCS
$12.17
▲
+0.00%
Chart
Valuation
Financials
Peers
News
OCS · K 線技術分析（即時、可互動）
basic
pro
快速分析（2–5 分鐘）
K 線圖載入中…
按上方「快速分析」，研究台會以這張 K 線為起點跑一輪快速回答：三個分析師視角（總經、基本面、技術面）加交易計畫與風險統計，一般約 2 分鐘，上游壅塞時最長約 5 分鐘。想要五隊深度研究與機構級報告，請在研究台把模式切到「深度」。
1-YEAR PRICE
一年走勢
RISK-OFF
252 BARS · -29.3% YOY
1-year price chart. Started at 17.22, currently 12.17, down 29.3 percent. Range 10.71 to 32.65 over 252 data points.
2025-09-05
$17.22 → $12.17 (-29.3%)
2026-09-04
§ Valuation
Loading § Valuation
§ Multi-Year Financials
Loading § Multi-Year Financials
§ Peers
Loading § Peers
§ Recent News
Loading § Recent News
編輯內容 · 非投資建議。
資料來源：Finnhub（報價 / 公司資料 / 新聞 / 同業）＋ Yahoo（統計）＋ SEC EDGAR XBRL（財務 + DCF）。伺服器端數值經 ISR 快取，最長 60 分鐘；報價則在你的瀏覽器裡即時更新。
VALUATION
確定性估值（SEC EDGAR + Finnhub）
—
NO DCF
DCF Fair Value
—
DCF vs Spot
—
Comps Fair Value
$16.45
WACC Used
+7.0%
Terminal g
+3.5%
判定: strong-sell
· peers $16.45 (+35.1%)
同業:
NOVN.SW PE24
GALD.SW PE55
SDZ.SW PE59
DESN.SW PE36
BIOV.SW
CURN.SW
ADXN.SW
ROP.SW PE23
⚠ DCF skipped: missing FCF or shares data from SEC EDGAR. Often the case for non-US issuers.
FINANCIALS
多年財務（SEC XBRL）
—
3 FY · NO YOY
FY
Revenue
Net Income
OCF
FCF
Assets
2025-12
—
-$99.0M
-$66.3M
—
$236.0M
2024-12
—
-$85.8M
-$48.9M
—
$120.4M
2023-12
—
-$88.8M
-$55.0M
—
$114.4M
PEERS
同業與產業對照
CALM
8 PEERS · FINNHUB
NOVN.SW
GALD.SW
SDZ.SW
DESN.SW
BIOV.SW
CURN.SW
ADXN.SW
ROP.SW
NEWS
近期新聞（過去 14 天）
CALM
10 HEADLINES · LAST 14 DAYS
Wall Street Analysts Believe Oculis Holding AG (OCS) Could Rally 199.75%: Here's is How to Trade
Zacks · 2026-08-31
Oculis Treats First Patient in Optic Neuritis Trial; Shares Up Pre-Bell
MT Newswires · 2026-08-24
First Patient Treated in PIONEER-1 Registrational Trial of Privosegtor for Optic Neuritis
GlobeNewswire · 2026-08-24
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
GlobeNewswire · 2026-08-14
Does Oculis Holding AG (OCS) Have the Potential to Rally 187.83% as Wall Street Analysts Expect?
Zacks · 2026-08-14
Oculis to Buy Accure's Global Development, Commercial Rights to Privosegtor
MT Newswires · 2026-08-10
Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company
GlobeNewswire · 2026-08-10
Oculis Holding AG (OCS) Reports Q2 Loss, Tops Revenue Estimates
Zacks · 2026-08-07